Customize your JAMA Network experience by selecting one or more topics from the list below.
Physicians in the United States, Canada, and Mexico
Physicians with current and valid licenses in the United States, Canada, or Mexico who read any 3 of the selected continuing medical education (CME) articles in this issue of Archives of Neurology, complete the CME Evaluation Form, and fax it to the number or mail it to the address at the bottom of the CME Evaluation Form are eligible for category 1 CME credit. There is no charge.
The American Medical Association (AMA) is accredited by the Accreditation Council for Continuing Medical Education to sponsor continuing medical education for physicians. The AMA designates this educational activity for up to 3 hours of category 1 CME credit per Archives of Neurology issue toward the AMA Physician's Recognition Award (PRA). Each physician should claim only those hours of credit that were actually spent in this educational activity.
Physicians in Other Countries
Physicians with current and valid licenses in the United States, Mexico, or Canada are eligible for CME credit even if they live or practice in other countries. Physicians licensed in other countries are also welcome to participate in this CME activity. However, the PRA is only available to physicians licensed in the United States, Canada, or Mexico.
Statement of Educational Purpose
The Archives of Neurology provides new evidence for the practice of neurology, neurosurgery, and other specialties whose goal is to improve the neurological health of all people. Original contributions, neurological reviews, neurology and public health, and history of neurology are among the categories of articles published, but all contributions receive a sympathetic reading by the Chief Editor. The journal's editorial board sets the initial framework for the types of articles published, which is then modified by feedback from editors, external peer reviewers, authors, and readers. We are keen to receive submissions from practicing neurologists to provide new insight for colleagues.
We want our readers to assess each article critically; this CME activity is active, not passive. Does the article contribute in some way to the practice of neurology? How could you modify your practice style to incorporate what you have learned? How can you acquire more information, challenge the authors' conclusions, or verify what you have read? Which of the articles in each issue is least helpful in your quest for the best and most applicable evidence?
To earn 1 hour of category 1 CME credit, you should read any 3 of the CME articles listed below and complete the CME Evaluation Form. To earn 3 hours of credit, read all of the articles listed below and complete the CME Evaluation Form. The CME Evaluation Form must be submitted within 4 weeks of the issue date. A certificate awarding up to 3 hours of category 1 CME credit will be faxed or mailed to you; it is then your responsibility to maintain a record of credit received. Questions about CME credit processing should be directed to The Blackstone Group; tel: (312) 419-0400, ext 225; fax: (312) 269-1636.
One of our goals is to assess continually the needs of our readers so we may enhance the educational effectiveness of the Archives of Neurology. To achieve this goal, we need your help. You must complete the CME Evaluation Form to receive credit.
CME Articles in This Issue of Archives of Neurology
The articles listed below may be read for CME credit.
Therapeutic Interventions Following Mammalian Spinal Cord Injury
Educational Objective: To review recent advances in the treatment of spinal cord injury.
Proton Magnetic Resonance Spectroscopy of the Motor Cortex in 70 Patients With Amyotrophic Lateral Sclerosis
Educational Objective: To evaluate proton magnetic resonance spectroscopy of the motor cortex in patients with amyotrophic lateral sclerosis.
Familial Amyotrophic Lateral Sclerosis With a Novel Leu126Ser Mutation in the Copper/Zinc Superoxide Dismutase Gene Showing Mild Clinical Features and Lewy Body–Like Hyaline Inclusions
Educational Objective: To examine neurogenetic attributes of familial amyotrophic lateral sclerosis.
Fluid-Attenuated Inversion Recovery Magnetic Resonance Imaging Detects Cortical and Juxtacortical Multiple Sclerosis Lesions
Educational Objective: To learn more about neuroimaging in multiple sclerosis.
Neurologic and Psychiatric Manifestations in a Family With a Mutation in Exon 2 of the Guanosine Triphosphate–Cyclohydrolase Gene
Educational Objective: To correlate neurogenetic and clinical characteristics in hereditary progressive dystonia/dopa-responsive dystonia.
Improvement in Chronic Ischemic Neuropathy After Intramuscular phVEGF165 Gene Transfer in Patients With Critical Limb Ischemia
Educational Objective: To evaluate vascular endothelial growth factor in critical limb ischemia.
Ictal Fear in Temporal Lobe Epilepsy: Surgical Outcome and Focal Hippocampal Changes Revealed by Proton Magnetic Resonance Spectroscopy Imaging
Educational Objective: To study ictal fear, neuroimaging, and surgical outcome in temporal lobe epilepsy.
Long-term Efficacy and Safety of Piracetam in the Treatment of Progressive Myoclonus Epilepsy
Educational Objective: To evaluate piracetam in progressive myoclonus epilepsy.
Spinocerebellar Ataxia Type 1 in China: Molecular Analysis and Genotype-Phenotype Correlation in 5 Families
Educational Objective: To correlate neurogenetic and clinical attributes of spinocerebellar ataxia in China.
Recurrence of Acute Disseminated Encephalomyelitis at the Previously Affected Brain Site
Educational Objective: To examine the clinical characteristics of recurrent acute disseminated encephalomyelitis.
Acute Severe Spinal Cord Dysfunction in Bacterial Meningitis in Adults: MRI Findings Suggest Extensive Myelitis
Educational Objective: To determine the value of spinal cord neuroimaging in adults with bacterial meningitis.
Medium-Chain Acyl Coenzyme A Dehydrogenase Deficiency: Occurrence in an Infant and His Father
Educational Objective: To learn about a family occurrence of medium-chain acyl CoA dehydrogenase deficiency.
Treatment of Myelopathy in Sjögren Syndrome With a Combination of Prednisone and Cyclophosphamide
Educational Objective: To read about advances in the treatment of progressive myelopathy in Sjögren syndrome.
After you have read any 3 (to earn 1 hour of category 1 CME credit) or all (to earn 3 hours of credit) of these articles, please complete the CME Evaluation Form.
Archives of NeurologyReader's Choice: Continuing Medical Education. Arch Neurol. 2001;58(5):840–841. doi:10.1001/archneur.58.5.840
Coronavirus Resource Center
Create a personal account or sign in to: